Prophylaxis for toxoplasmosis in immunosuppressed patients;La prophilaxie de la toxoplasmose chez les patients immunodeprimes

Annales de Medecine Interne

Volumn 148, Issue 3, 1997, Pages 235-239

  Morlat, Philippe ^a   Leport, Catherine ^b  

^a HÔPITAL SAINT ANDRÉ   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Immunosuppression; Prophylaxis; Toxoplasma gondii

Indexed keywords

ATOVAQUONE; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE;

ANTIBIOTIC PROPHYLAXIS; CHEMOPROPHYLAXIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; ORGAN TRANSPLANTATION; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS; AIDS RELATED COMPLEX; HUMAN; RISK FACTOR;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; ORGAN TRANSPLANTATION; RISK FACTORS; TOXOPLASMOSIS;

EID: 0030871356     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. HOLLIMAN RE, JOHNSON JD, ADAMS S, PEPPER JR : Toxoplasmosis and heart transplantation. J Heart Lung Transplant 1991 ; 10 : 608-10.
2. MICHAELS MG, WALD ER, FRICKER FJ, DEL NIDO PJ, ARMITAGE J : Toxoplasmosis in pediatric recipient of heart transplants. Clin Infect Dis 19921 ; 14 : 847-51.
3. DEROUIN F, DEVERGIE A, AUBER P et al : Toxoplasmosis in bone marrow-transplant recipients : report of seven cases and review. Clin Infect Dis 1992 ; 15 : 267-70.
4. ROUSSEAU F, LEPORT C, VILDE JL : Prévention de la toxoplasmose chez les immunodéprimés. Med Mal Infect 1993 ; 23 : 201-10.
5. LUFT BJ, REMINGTON JS : Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992 ; 15 : 211-22.
6. MORLAT P, RAGNAUD JM, GIN H et al : La toxoplasmose cérébrale au cours du SIDA. Med Mal Infect 1993 ; 23 : 183-9.
7. RICHARDS FO, KOVACS JA, LUFT BJ : Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995 ; 21 (suppl 1) : S 49-56.
8. LEPORT C, CHENE G, MORLAT P et al : Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection : a double blind placebo-controlled trial. J Infect Dis 1996 ; 173 : 91-7.
9. DEROUIN F, PUEYO S, MORLAT P et al : Predictive value of Toxoplasma gondii antibody titer on the occurence of cerebral toxoplasmosis in HIV infected patients [abstract : 136]. In : Final program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, American Society for Microbiology, 1995 : 211.
10. LEPORT C, RAFFI F, MATHERON S et al : Treatment of central nervous system toxoplasmosis with Pyrimethamine-Sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med 1988 ; 84 : 94-100.
11. HFALD A, FLEPP M, CHAVE JP et al : Treatment of cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study. Am Intern Med 1991 ; 115 : 760-3.
12. KATLAMA C, DE WIT S, GUICHARD A et al : A randomized european trial comparing Pyrimethamine-Clindamycin to Pyrimethamine-Sulfadiazine in AIDS toxoplasmic encephalitis [abstract 1215]. In : Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington D.C., American Society of Microbiology, 1992.
13. PODZAMCZER D., MIRO JM, BOLAO F et al : Twice-Weekly maintenance therapy with Sulfadiazine-Pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1995 ; 123 : 175-80.
14. DE GANS J, PORTEGIES P, REISS P, TROOST D, VAN GOOL T, LANGE JMA : Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS. J Acquir Immune Defic Synd 1992 ; 5 : 137-42.
15. LACASSIN F, SCHAFEO D, PERRONNE C et al : Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1995 ; 39 : 276-7.
16. HARDY WD, FEINBERG J, FINKELSTEIN DM et al : A controlled trial of Trimethoprim-Sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992 ; 327 : 1842-8.
17. MAY T., BEUSCART C., LECLERQ P et al : Trimethoprim-Sulfamethoxazole versus aerolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia : a prospective, randomized, controlled clinical trial. J Acquir Immune Defic Synd 1994 ; 7 : 457-62.
18. MICHELET C, RAFFI F, BESNIER JM et al : Cotrimoxazole (CMX) versus aerolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia (PCP) [abstract 1071]. In : Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington DC, American Society for Microbiology, 1993 ; 315.
19. OKSENHENDLER E, CHARREAU I, TOURNERIE C, AZIHARY M, CARBON C, ABOILKER JP : Toxoplasma gondii in advanced HIV infection. AIDS 1994 ; 8 : 483-7.
20. CARR A, TINDALL B, BREW BJ et al : Low-dose Trimethoprim-Sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992 ; 117 : 106-111.
21. GALLANT JE, MOORE RD, CHAISSON RE : Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 1994 ; 120 : 932-44.
22. ZAMORA L, MALLOLAS J, MIRO JM et al : Primary prophylaxis of toxoplasmic encephalitis (TE) and P. carinii pneumonia (PCP) in HIV patients [abstract : I 224]. In : Final program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, American Society for Microbiology, 1995 ; 245.
23. CLOTET B, ROMEU J, SIRERA G : Cerebral toxoplasmosis and prophylaxis for Pneumocystis carinii pneumonia. Ann Intern Med 1992 ; 117 : 169.
24. GIRARD PM, LANDMAN R, GAUDEBOUT C et al : Dapsone-Pyrimethamine compared with aerolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993 ; 328 : 1514-20.
25. JORDE UP, HOROWITZ HW, WORMSER GP : Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole intolerant HIV infected individuals. AIDS 1993 ; 7 : 355-9.
26. SALMON-CERON D, FONTBONNE A, SABA J et al : Lower survival in AIDS patients receiving Dapsone compared with aerolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. J Infect Dis 1995 ; 172 : 656-64.
27. ANTINORI A, MURRI R, AMMASSARI A et al : Aerolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of P. carinii pneumonia (PCP) and toxoplasmic encephalitis. AIDS 1995 ; 9 : 1343-50.
28. TORRES RA, BARR M, THORN M et al : Randomized trial of Dapsone and aerolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Am J Med 1993 ; 95 : 573-83.
29. JACOBSON MA, BESCH CL, CHILD C et al : Prophylaxis with Pyrimethamine for toxoplasmic encephalitis in patients with advanced HIV disease : results of a randomized trial. J Infect Dis 1994 ; 169 : 384-94.
30. NAVIN TR, MILLER KD : Adverse reactions associated with Pyrimethamine-Sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS. Lancet 1985 ; I : 1332.
31. JACOBSON MA, BESCH CL, CHILD C et al : Toxicity of Clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Lancet 1992 ; 339 : 333-4.
32. WREGHITT TG, HAKIM M, GRAY JJ et al : Toxoplasmosis in heart and heart lung transplant recipients. J Clin Pathol 1989 ; 42 : 194-9.